Lepto Vaccine

Verify with FDA CVM →

453 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
453
Total Reports
42
Deaths Reported
930.0%
Death Rate

Active Ingredients

Lepto Vaccine

Administration Routes

UnknownParenteralSubcutaneousIntra-ArterialOral

Species Affected

Dog 453

Most Affected Breeds

Retriever - Labrador 64
Retriever - Golden 25
Shepherd Dog - German 22
Boxer (German Boxer) 22
Crossbred Canine/dog 20
Shih Tzu 19
Pit Bull 15
Shepherd Dog - Australian 12
Dachshund (unspecified) 12
Bulldog - French 12

Most Reported Reactions

Vomiting 146
Emesis 89
Lethargy (see also Central nervous system depression in 'Neurological') 81
Diarrhoea 67
Other abnormal test result NOS 34
Seizure NOS 32
Lack of efficacy - NOS 25
Decreased appetite 24
Behavioural disorder NOS 22
Death 21
Not eating 21
Shaking 20

Outcome Breakdown

Recovered/Normal
217 (47.9%)
Outcome Unknown
99 (21.9%)
Ongoing
75 (16.6%)
Died
23 (5.1%)
Recovered with Sequela
20 (4.4%)
Euthanized
19 (4.2%)

Data Summary

Metric Value
Total adverse event reports 453
Reports involving death 42
Case-fatality rate (reported events) 930.0%
Distinct species in reports 1
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Lepto Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 453 adverse event reports referencing Lepto Vaccine, including 42 reports in which the animal died — a 930.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Lepto Vaccine. Reported administration routes include Unknown, Parenteral, Subcutaneous, Intra-Arterial. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Lepto Vaccine reports are Dog (453 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (64), Retriever - Golden (25), Shepherd Dog - German (22) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Lepto Vaccine are Vomiting (146), Emesis (89), Lethargy (see also Central nervous system depression in 'Neurological') (81), Diarrhoea (67). Of the 453 reports with a coded outcome, Recovered/Normal is the leading category at 47.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Lepto Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial